ZA923913B - Fatty acid compositions - Google Patents

Fatty acid compositions

Info

Publication number
ZA923913B
ZA923913B ZA923913A ZA923913A ZA923913B ZA 923913 B ZA923913 B ZA 923913B ZA 923913 A ZA923913 A ZA 923913A ZA 923913 A ZA923913 A ZA 923913A ZA 923913 B ZA923913 B ZA 923913B
Authority
ZA
South Africa
Prior art keywords
fatty acid
acid compositions
glycerol
compositions
dlmg
Prior art date
Application number
ZA923913A
Other languages
English (en)
Inventor
David Frederick Horrobin
Frederick Horrobin David
Yung-Sheng Huang
Huang Yung-Sheng
Original Assignee
Efamol Holdings
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Efamol Holdings filed Critical Efamol Holdings
Publication of ZA923913B publication Critical patent/ZA923913B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS, COOKING OILS
    • A23D9/00—Other edible oils or fats, e.g. shortenings, cooking oils
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/52—Esters of acyclic unsaturated carboxylic acids having the esterified carboxyl group bound to an acyclic carbon atom
    • C07C69/587—Monocarboxylic acid esters having at least two carbon-to-carbon double bonds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Food Science & Technology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Polymers & Plastics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Dermatology (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Fats And Perfumes (AREA)
  • Cosmetics (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Edible Oils And Fats (AREA)
  • Detergent Compositions (AREA)
  • Logic Circuits (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Junction Field-Effect Transistors (AREA)
  • Amplifiers (AREA)
ZA923913A 1991-06-03 1992-05-27 Fatty acid compositions ZA923913B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB919111900A GB9111900D0 (en) 1991-06-03 1991-06-03 Fatty acid compositions

Publications (1)

Publication Number Publication Date
ZA923913B true ZA923913B (en) 1993-02-24

Family

ID=10695999

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA923913A ZA923913B (en) 1991-06-03 1992-05-27 Fatty acid compositions

Country Status (20)

Country Link
US (4) US5328691A (no)
EP (1) EP0520624B1 (no)
JP (1) JP2704922B2 (no)
KR (2) KR100274727B1 (no)
AT (1) ATE136214T1 (no)
AU (1) AU652827B2 (no)
CA (1) CA2069600C (no)
DE (1) DE69209571T2 (no)
DK (1) DK0520624T3 (no)
ES (1) ES2085567T3 (no)
FI (1) FI103867B (no)
GB (1) GB9111900D0 (no)
GR (1) GR3019840T3 (no)
HK (1) HK4597A (no)
IE (1) IE75224B1 (no)
NO (1) NO180804C (no)
NZ (1) NZ242898A (no)
SG (1) SG49739A1 (no)
TW (1) TW288975B (no)
ZA (1) ZA923913B (no)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU673700B2 (en) * 1993-01-27 1996-11-21 Scotia Holdings Plc Triglycerides
GB9304746D0 (en) * 1993-03-09 1993-04-28 Scotia Holdings Plc Treatment of viral infections
FR2706304B1 (fr) * 1993-06-15 1995-09-01 Carita Sa Utilisation des huiles de Chaulmoogra dans le domaine cosmétique et pharmaceutique, notamment en dermatologie, pour harmoniser la pigmentation de la peau.
GB9325445D0 (en) 1993-12-13 1994-02-16 Cortecs Ltd Pharmaceutical formulations
GB9403855D0 (en) * 1994-03-01 1994-04-20 Scotia Holdings Plc Fatty acid derivatives
NZ280017A (en) * 1994-09-21 1997-06-24 Scotia Holdings Plc Use of n-6 or n-3 series essential fatty acid (efa), and optionally an oestrogen, to make a medicament to treat or prevent hormone replacement therapy (hrt) associated breast pain in peri- or postmenopausal women; medicaments containing the efa and estrogen.
EP0711503A3 (en) * 1994-11-14 1997-11-26 Scotia Holdings Plc Milk fortified with GLA and/or DGLA
US5639460A (en) * 1995-06-07 1997-06-17 Raymond; Hal C. Aqueous plant extract having antiviral activity
US5959131A (en) * 1995-12-07 1999-09-28 Kraft Foods, Inc. Nutritionally superior fat for food compositions
US6255505B1 (en) 1996-03-28 2001-07-03 Gist-Brocades, B.V. Microbial polyunsaturated fatty acid containing oil from pasteurised biomass
AU731785B2 (en) * 1996-03-28 2001-04-05 Gist-Brocades B.V. Preparation of microbial polyunsaturated fatty acid containing oil from pasteurised biomass
DK0906414T4 (en) * 1996-03-28 2015-11-16 Dsm Ip Assets Bv PROCESS FOR THE PREPARATION OF A granular MICROBIAL BIOMASS AND ISOLATION OF VALUABLE COMPOUNDS THENCE
ES2283020T3 (es) 1997-07-16 2007-10-16 Metacure Nv Controlador del musculo liso.
US7138431B1 (en) 1998-02-23 2006-11-21 Wake Forest University Dietary control of arachidonic acid metabolism
US6107334A (en) * 1998-02-23 2000-08-22 Wake Forest University Dietary control of arachidonic acid metabolism
US8666495B2 (en) 1999-03-05 2014-03-04 Metacure Limited Gastrointestinal methods and apparatus for use in treating disorders and controlling blood sugar
GB9918023D0 (en) * 1999-07-30 1999-09-29 Unilever Plc Skin care composition
US6737084B2 (en) * 2000-06-27 2004-05-18 Qualilife Compositions and methods for enhancing or treating female sexual response
US6506412B2 (en) * 2000-11-29 2003-01-14 Sciencebased Health Treatment of dry eye syndrome
ES2712854T3 (es) 2002-06-19 2019-05-16 Dsm Ip Assets Bv Aceite microbiano y procedimientos para su procesamiento
WO2004012753A1 (en) * 2002-07-31 2004-02-12 Helfried Hans Rudolf Crede Pharmaceutical composition containing black cumin oil, flax oil and borago oil
US7255972B2 (en) 2002-10-23 2007-08-14 Az Electronic Materials Usa Corp. Chemically amplified positive photosensitive resin composition
US20050123500A1 (en) * 2003-01-31 2005-06-09 The Procter & Gamble Company Means for improving the appearance of mammalian hair and nails
JP2006524187A (ja) * 2003-01-31 2006-10-26 ザ プロクター アンド ギャンブル カンパニー 哺乳類のケラチン組織の外観を改善する手段
GB0311081D0 (en) 2003-05-14 2003-06-18 Btg Internat Limted Treatment of neurodegenerative conditions
US8792985B2 (en) 2003-07-21 2014-07-29 Metacure Limited Gastrointestinal methods and apparatus for use in treating disorders and controlling blood sugar
WO2005018632A1 (en) 2003-08-18 2005-03-03 Btg International Limited Treatment of neurodegenerative conditions
JP2006061021A (ja) * 2004-08-24 2006-03-09 Suntory Ltd １種類の高度不飽和脂肪酸残基３個から成るトリグリセライドの製造方法、およびその利用
US8343753B2 (en) * 2007-11-01 2013-01-01 Wake Forest University School Of Medicine Compositions, methods, and kits for polyunsaturated fatty acids from microalgae
GB0907413D0 (en) 2009-04-29 2009-06-10 Equateq Ltd Novel methods
JP2010042037A (ja) * 2009-11-26 2010-02-25 Suntory Holdings Ltd １種類の高度不飽和脂肪酸残基３個から成るトリグリセライドの製造方法、およびその利用
WO2011092710A2 (en) 2010-02-01 2011-08-04 Metacure Limited Gastrointestinal electrical therapy
US20120252888A1 (en) * 2011-03-29 2012-10-04 Palupa Medical Ltd. Compositions and Methods for Treating Neurologic Disorders
US8293790B2 (en) 2011-10-19 2012-10-23 Dignity Sciences Limited Pharmaceutical compositions comprising DGLA and benzoyl peroxide and methods of use thereof
WO2015071766A1 (en) 2013-11-15 2015-05-21 Dignity Sciences Limited Pharmaceutically acceptable salts of polyunsaturated hydroxy fatty acids
SG10201912145VA (en) 2014-06-04 2020-02-27 Dignity Sciences Ltd Pharmaceutical compositions comprising dgla and use of same
JP6816012B2 (ja) 2015-03-26 2021-01-20 ティベリオ ブリュジーズ 多価不飽和脂肪酸の精製方法
EP3294282A1 (en) 2015-05-13 2018-03-21 DS Biopharma Limited Compositions comprising 15-oxo-epa or 15-oxo-dgla and methods of making and using same
US20210315851A1 (en) 2020-04-03 2021-10-14 Afimmune Limited Compositions comprising 15-hepe and methods of treating or preventing hematologic disorders, and/or related diseases

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4172149A (en) * 1978-01-30 1979-10-23 Westwood Pharmaceuticals, Inc. Method for treating living skin exhibiting excessive sebum secretion
DE2942021A1 (de) * 1979-10-17 1981-04-30 Bristol Myers Co Dermatologisches mittel
FR2490631A1 (fr) * 1980-09-24 1982-03-26 Roussel Uclaf Nouvelle composition lipidique utilisable en dietetique, reanimation et therapeutique
US5145686A (en) * 1982-02-03 1992-09-08 Efamol Limited Topical pharmaceutical compositions
US5011855A (en) * 1982-04-16 1991-04-30 Nestec S.A. Cosmetic and dermatological compositions containing γ-linolenic acid
DE3368377D1 (en) * 1982-04-16 1987-01-29 Nestle Sa Lipid composition for oral, enteral or parenteral feeding
EP0093516B1 (en) * 1982-04-29 1986-10-01 Efamol Limited Pharmaceutical composition
GB8302708D0 (en) * 1983-02-01 1983-03-02 Efamol Ltd Pharmaceutical and dietary composition
FR2569347B1 (fr) * 1984-08-22 1987-10-23 Mollet Marc Composition lipidique favorisant la pousse des phaneres et produits cosmetiques en renfermant
GB8516906D0 (en) * 1985-07-04 1985-08-07 Efamol Ltd Pharmaceutical & dietary composition
GB8524275D0 (en) * 1985-10-02 1985-11-06 Efamol Ltd Pharmaceutical & dietary compositions
FR2588187B1 (fr) * 1985-10-07 1989-04-14 Rochas Parfums Nouvelles compositions cosmetiques ou dermatologiques riches en acides gras essentiels presents a la fois sous forme de triglycerides et sous forme libre ou salifiee
JPS6284041A (ja) * 1985-10-08 1987-04-17 Nitto Electric Ind Co Ltd γ−リノレン酸含有包接物
JPS62187425A (ja) * 1985-10-14 1987-08-15 Michio Nakanishi リノレン酸系化合物含有組成物
SE8604117D0 (sv) * 1986-09-29 1986-09-29 Kabivitrum Ab Composition
JPH0832628B2 (ja) * 1986-12-17 1996-03-29 株式会社ミドリ十字 トリグリセリド組成物
JPS6451496A (en) * 1987-08-21 1989-02-27 Nippon Oils & Fats Co Ltd Method of refining oil containing gamma-linolenic acid
FR2623692B1 (fr) * 1987-11-30 1991-05-03 Vernin Jean Gilles Nouvelle huile dietetique
GB8729153D0 (en) * 1987-12-14 1988-01-27 Efamol Ltd Fatty acid compositions
IE63225B1 (en) * 1988-09-13 1995-04-05 Efamol Holdings Use of fatty acids in the treatment of myalgic encephalomyelitis
GB9001121D0 (en) * 1990-01-18 1990-03-21 Efamol Holdings Efa compositions and therapy

Also Published As

Publication number Publication date
DK0520624T3 (da) 1996-05-06
ATE136214T1 (de) 1996-04-15
HK4597A (en) 1997-01-17
FI922542A (fi) 1992-12-04
ES2085567T3 (es) 1996-06-01
US5328691A (en) 1994-07-12
US5614208A (en) 1997-03-25
US5552150A (en) 1996-09-03
AU652827B2 (en) 1994-09-08
NO922183D0 (no) 1992-06-02
NO180804C (no) 1997-07-02
FI103867B1 (fi) 1999-10-15
GB9111900D0 (en) 1991-07-24
SG49739A1 (en) 1998-06-15
JP2704922B2 (ja) 1998-01-26
FI922542A0 (fi) 1992-06-02
AU1727892A (en) 1992-12-10
EP0520624B1 (en) 1996-04-03
NZ242898A (en) 1994-12-22
KR100277424B1 (ko) 2000-12-15
EP0520624A1 (en) 1992-12-30
DE69209571T2 (de) 1996-09-05
IE75224B1 (en) 1997-08-27
TW288975B (no) 1996-10-21
NO922183L (no) 1992-12-04
KR100274727B1 (ko) 2000-12-15
CA2069600A1 (en) 1992-12-04
JPH05201924A (ja) 1993-08-10
KR930000664A (ko) 1993-01-15
US5620701A (en) 1997-04-15
DE69209571D1 (de) 1996-05-09
CA2069600C (en) 2004-05-04
NO180804B (no) 1997-03-24
IE921663A1 (en) 1992-12-16
FI103867B (fi) 1999-10-15
GR3019840T3 (en) 1996-08-31

Similar Documents

Publication Publication Date Title
GB9111900D0 (en) Fatty acid compositions
ES2094788T3 (es) Composicion nutritiva.
GB8821129D0 (en) Cosmetic composition
ZA943120B (en) Lipid composition for cosmetic products
GB8519426D0 (en) Composition for personal care products
DE60040096D1 (de) Zusammensetzung enthaltend ozonisierte öle und/oder andere natürliche und/oder synthetische ozonizierte produkte und ihre verwendung in pharmazeutischen, kosmetischen, diätetischen oder nahrungsergänzenden zusammensetzungen in human- und veterinärgebieten
SG81882A1 (en) Retinoid composition
PH24425A (en) Improved flunarizine-containing compositions
AU2072088A (en) Agent containing salicylic acid for treating lepidosis
ES2081888T3 (es) Proteccion contra la oxidacion de un producto alimenticio, cosmetico o farmaceutico.
ES2009248A6 (es) Composicion dietetica a base de algas que contengan selenio.
ES2009249A6 (es) Composicion cosmetica regeneradora de la piel a base de algas que contengan selenio.
ES2026825A6 (es) Composicion de cuerpos grasos para productos cosmeticos y procedimiento para prepararla.
FR2627060B1 (fr) Creme fraiche modifiee et beurre enrichi a l'huile vegetale
EP0272878A3 (en) Dentifrice composition
RO95866B1 (ro) Crema de fata cu biostimulatori pentru ten uscat
EP0231925A3 (en) Hair care compositions